 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/04/2026 |
$48.42 |
$49.47 |
$48.20 |
$49.08 |
665.30K | | 02/05/2026 |
$48.98 |
$50.10 |
$48.93 |
$49.37 |
565.50K | | 02/06/2026 |
$50.01 |
$51.99 |
$50.01 |
$51.65 |
893.90K | | 02/09/2026 |
$51.75 |
$51.96 |
$50.36 |
$51.30 |
654.40K | | 02/10/2026 |
$51.44 |
$51.93 |
$50.64 |
$51.18 |
495.00K |
|
|
| Supernus Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. Co. is also developing a range of novel CNS product candidates, including new potential treatments for hypomobility in PD, epilepsy, depression, and other CNS disorders. | |
|
Supernus Pharmaceuticals (SUPN) has the following price history information. Looking back at SUPN historical stock prices for the last five trading days, on February 04, 2026, SUPN opened at $48.42, traded as high as $49.47 and as low as $48.20, and closed at $49.08. Trading volume was a total of 665.30K shares. On February 05, 2026, SUPN opened at $48.98, traded as high as $50.10 and as low as $48.93, and closed at $49.37. Trading volume was a total of 565.50K shares. On February 06, 2026, SUPN opened at $50.01, traded as high as $51.99 and as low as $50.01, and closed at $51.65. Trading volume was a total of 893.90K shares. On February 09, 2026, SUPN opened at $51.75, traded as high as $51.96 and as low as $50.36, and closed at $51.30. Trading volume was a total of 654.40K shares. On February 10, 2026, SUPN opened at $51.44, traded as high as $51.93 and as low as $50.64, and closed at $51.18. Trading volume was a total of 495.00K shares.
SUPN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Supernus Pharmaceuticals shares, starting with a $10,000 purchase of SUPN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/12/2016 |
|
| End date: |
02/10/2026 |
|
| Start price/share: |
$12.84 |
|
| End price/share: |
$51.18 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
298.60% |
|
| Average Annual Total Return: |
14.83% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$39,876.61 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 02/04/2026 | $49.08 | | 02/05/2026 | $49.37 | | 02/06/2026 | $51.65 | | 02/09/2026 | $51.30 | | 02/10/2026 | $51.18 |
|
|
Free SUPN Email Alerts:
